Jun Ji-hyun and Lee Min-ho selected Mulz Aesthetics Ulcerapi Prime Asia Pacific Ambassador

Jul 14, 2025

Jun Ji-hyun and Lee Min-ho selected Mulz Aesthetics Ulcerapi Prime Asia Pacific Ambassador
　◇전지현



Jun Ji-hyun and Lee Min-ho selected Mulz Aesthetics Ulcerapi Prime Asia Pacific Ambassador
　◇이민호
Actors Jeon Ji-hyun and Lee Min-ho have been chosen as the new Asia Pacific Ambassador for Mults Aesthetics "Ulsserafi Prime."

Mulz Aesthetics (hereinafter referred to as Mulz) selected two actors as the new Asia Pacific ambassador for its next-generation ultrasonic lifting device 'Ultherapy Prime™ (a focused ultrasonic stimulation system medical device)' at the Grand Ballroom in Grand Hyatt Seoul on the 11th and unveiled a new campaign.

Together with Jun Ji-hyun and Lee Min-ho, Mulz will continue the 'See My Skin, Lift My Way' campaign for the Asia-Pacific region. The campaign emphasizes that the best moments of life are not temporary, but a journey of continuous evolution.




Jun Ji-hyun and Lee Min-ho selected Mulz Aesthetics Ulcerapi Prime Asia Pacific Ambassador
Sylvia Lee, senior vice president of marketing for Multz Asia Pacific and China, introduces Ulcerapi Prime™'s new campaign, "Together with Jun Ji-hyun and Lee Min-ho, Ambassador, who are continuing their new challenges every time, we will work hard to realize Multz's mission to help everyone find their inner confidence and true beauty."," he said.

Ulcerapi Prime™ is a U.S. FDA-approved next-generation ultrasound lifting platform with real-time imaging. Through the patented real-time ultrasound imaging technology 'DeepSEE™', the skin structure can be directly identified and performed, and three transducers that control the depth at which energy is irradiated deliver precise and consistent energy to the required layer, which can be expected to achieve safe and effective results. It supports ultra-personalized lifting procedures optimized for individual skin thickness and condition because clearer image implementation is possible through ultrasound fields and improved software that are twice as large as existing Ulcera.

The results of a survey of 1,500 consumers in the Asia Pacific region were also released at the event. According to the survey, 94% of respondents prioritize 'tailored procedures' over uniform options, and 80% of respondents said they were willing to pay more for super-personal procedures to achieve longer-term and more effective results.




With FDA-approved technology and safety, experience with more than 3 million procedures around the world, and a lifting protocol optimized for Koreans, Ulcerapi Prime™ will lead the era of customized lifting procedures that are clearer, more delicate and more accurate, and will continue to be with Mulz, CEO of Malz Aesthetics Korea" he said.



This article was translated by Naver AI translator.